Literature DB >> 23580900

Inflammatory bowel disease register: Steps towards Crohn's & colitis foundation of Saudi Arabia (CCFSA).

Ibrahim Masoodi1, Khalid Alsayari, Jamal Albishri.   

Abstract

Inflammatory bowel diseases (IBD) are among the leading cause of financial burden, morbidity and employee absenteeism in developed countries because of their chronic remitting and relapsing courses. IBD is estimated to affect the Canadian economy to the tune of 100 million dollars per year. The data regarding exact prevalence in Asian countries, including Saudi Arabia, is still incomplete as there is underreporting and lack of proper registry of the diagnosed cases. The prevalence of inflammatory bowel disease (Ulcerative colitis, Crohn's disease) has increased over the last decade in Saudi Arabia due to increased IBD awareness among population, as more patients seek medical help and also due to unknown reasons. There is a need of proper registration of IBD patients and establishment of Crohn's & colitis foundation of Saudi Arabia (CCFSA) as in other parts of the world. The Crohn's & colitis foundation of Saudi Arabia will be a forum which will co ordinate IBD treatment and research in the country in addition to health education among IBD population.

Entities:  

Year:  2012        PMID: 23580900      PMCID: PMC3616950          DOI: 10.12816/0006002

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  12 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

Authors:  Edward V Loftus
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

3.  A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis.

Authors:  V Binder
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

4.  The course of inflammatory bowel disease during pregnancy and postpartum.

Authors:  M Mogadam; B I Korelitz; S W Ahmed; W O Dobbins; P J Baiocco
Journal:  Am J Gastroenterol       Date:  1981-04       Impact factor: 10.864

5.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

Authors:  K W Schroeder; W J Tremaine; D M Ilstrup
Journal:  N Engl J Med       Date:  1987-12-24       Impact factor: 91.245

6.  Epidemiology of juvenile-onset inflammatory bowel disease in central Saudi Arabia.

Authors:  Mohammad Issa El Mouzan; Asaad Mohammad Abdullah; Mohammad Talal Al Habbal
Journal:  J Trop Pediatr       Date:  2005-06-09       Impact factor: 1.165

7.  Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.

Authors:  Ibrahim Masoodi; Rakesh Kochhar; Usha Dutta; Chetana Vaishnavi; Kaushal K Prasad; Kim Vaiphei; Sukhminder Kaur; Kartar Singh
Journal:  J Gastroenterol Hepatol       Date:  2009-11       Impact factor: 4.029

8.  Inflammatory bowel disease in Kuwait.

Authors:  B Al-Nakib; S Radhakrishnan; G S Jacob; H Al-Liddawi; A Al-Ruwaih
Journal:  Am J Gastroenterol       Date:  1984-03       Impact factor: 10.864

9.  Epidemiology and outcome of Crohn's disease in a teaching hospital in Riyadh.

Authors:  Abdullah S Al-Ghamdi; Ibrahim A Al-Mofleh; Rashed S Al-Rashed; Saleh M Al-Amri; Abdulrahman M Aljebreen; Arthur C Isnani; Reda El-Badawi
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

10.  Patterns of colonic involvement at initial presentation in ulcerative colitis: a retrospective study of 46 newly diagnosed cases.

Authors:  Marie E Robert; Mark Skacel; Thomas Ullman; Charles N Bernstein; Kirk Easley; John R Goldblum
Journal:  Am J Clin Pathol       Date:  2004-07       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.